Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Henry N Ginsberg, Chris J Packard, M John Chapman, Jan Borén, Carlos A Aguilar-Salinas, Maurizio Averna, Brian A Ference, Daniel Gaudet, Robert A Hegele, Sander Kersten, Gary F Lewis, Alice H Lichtenstein, Philippe Moulin, Børge G Nordestgaard, Alan T Remaley, Bart Staels, Erik S G Stroes, Marja-Riitta Taskinen, Lale S Tokgözoğlu, Anne Tybjaerg-Hansen, Jane K Stock, Alberico L Catapano

Open source

DOI
10.1093/eurheartj/ehab551
Published
2021-09-02
Container
European Heart Journal
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehab551,
  title = {Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society},
  author = {Henry N Ginsberg and Chris J Packard and M John Chapman and Jan Borén and Carlos A Aguilar-Salinas and Maurizio Averna and Brian A Ference and Daniel Gaudet and Robert A Hegele and Sander Kersten and Gary F Lewis and Alice H Lichtenstein and Philippe Moulin and Børge G Nordestgaard and Alan T Remaley and Bart Staels and Erik S G Stroes and Marja-Riitta Taskinen and Lale S Tokgözoğlu and Anne Tybjaerg-Hansen and Jane K Stock and Alberico L Catapano},
  year = {2021},
  journal = {European Heart Journal},
  doi = {10.1093/eurheartj/ehab551},
  url = {https://doi.org/10.1093/eurheartj/ehab551}
}

RIS

TY  - JOUR
TI  - Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
AU  - Henry N Ginsberg
AU  - Chris J Packard
AU  - M John Chapman
AU  - Jan Borén
AU  - Carlos A Aguilar-Salinas
AU  - Maurizio Averna
AU  - Brian A Ference
AU  - Daniel Gaudet
AU  - Robert A Hegele
AU  - Sander Kersten
AU  - Gary F Lewis
AU  - Alice H Lichtenstein
AU  - Philippe Moulin
AU  - Børge G Nordestgaard
AU  - Alan T Remaley
AU  - Bart Staels
AU  - Erik S G Stroes
AU  - Marja-Riitta Taskinen
AU  - Lale S Tokgözoğlu
AU  - Anne Tybjaerg-Hansen
AU  - Jane K Stock
AU  - Alberico L Catapano
PY  - 2021
JO  - European Heart Journal
DO  - 10.1093/eurheartj/ehab551
UR  - https://doi.org/10.1093/eurheartj/ehab551
ER  - 

APA

Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., Lewis, G. F., Lichtenstein, A. H., Moulin, P., Nordestgaard, B. G., Remaley, A. T., Staels, B., Stroes, E. S. G., Taskinen, M., Tokgözoğlu, L. S., Tybjaerg-Hansen, A., Stock, J. K., & Catapano, A. L. (2021). Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society. European Heart Journal. https://doi.org/10.1093/eurheartj/ehab551

Source records